12
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

Thiourea and benzamide compounds, composition and methods of treating or preventing inflammatory diseases and atherosclerosis

Pages 245-249 | Published online: 25 Feb 2005
 

Abstract

The authors have synthesised a series of thiourea and benzamide compounds and claim their use as potential anti-inflammatory and/or anti-atherosclerotic drugs. 280 Compounds were synthesised and tested for lipoxygenase (LO) inhibitory activity in an in vitro assay system using the purified rabbit reticulocyte 15-LO. Some of them were shown to be potent LO inhibitors with IC50 values as low as 2 nM. In an in vitro model of inflammation, several compounds inhibited monocyte recruitment with an EC50 in the lower μM-range and some inhibitors slowed down the development of atherosclerotic lesions in an animal atherosclerosis model. However, there was no correlation between LO inhibition and anti-atherogenic or anti-inflammatory activity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.